| Financial Year |
March 31 2023 |
| Monetary Funds |
81,030,140.48 |
| Held-for-trading Financial Assets |
230,636,883.33 |
| Notes Receivable |
68,645,180.09 |
| Accounts Receivable |
208,543,020.19 |
| Advances to Suppliers |
635,484.22 |
| Other Receivables |
4,983,428.64 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
146,627,406.95 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
14,738,320.51 |
| Total Current Assets |
755,839,864.41 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
498,826.75 |
| Investment Properties |
2,251,579.52 |
| Fixed Assetes |
356,075,324.42 |
| Under-construction Projects |
26,633,605.83 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
49,249,560.01 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
-- |
| Deferred Income Tax Assets |
30,898,440.49 |
| Other Non-Current Assets |
74,946,725.16 |
| Sub-Total of Non-Current Assets |
677,515,260.34 |
| Total Assets |
1,433,355,124.75 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
28,858,014.52 |
| Accounts Payable |
54,398,290.92 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
8,665,528.42 |
| Taxes Payable |
3,546,532.22 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
11,120,812.34 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
813,599.11 |
| Other Current Liabilities |
19,847,868.06 |
| Sub-Total of Current Liabilities |
136,312,627.23 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
43,370,413.38 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
116,263,921.66 |
| Total Liabilities |
252,576,548.89 |
| Paid-In Capital(Or Share Stock) |
485,908,830.00 |
| Capital Surplus |
126,427,735.48 |
| Surplus Reserve |
88,141,017.21 |
| LESS:Treasury Stock |
40,000,000.00 |
| Undistributed Profits |
427,999,314.01 |
| Minority Stockholder's Interest |
88,422,075.99 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,092,356,499.87 |
| Owner's Equity（Stockholder's Equity） |
1,180,778,575.86 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,433,355,124.75 |
